Synfacts 2023; 19(08): 0830
DOI: 10.1055/s-0042-1752721
Innovative Drug Discovery and Development

Design and Synthesis of the First-in-Class MC4R Antagonist, PF-07258669 with [4,5]-Spirocyclic Core

Contributor(s):
Antonia F. Stepan (Roche)
,
Seong Heon Kim (Hyundai Pharm)


Publication History

Article published online:
14 July 2023

© 2023. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany